Filter
2234
Filtered Results: 2234
Text search:
medicines
and
related
substances
Featured
Recommendations
249
New Publications
515
Language
Document type
No document type
1285
Guidelines
315
Studies & Reports
304
Manuals
170
Strategic & Response Plan
68
Training Material
51
Fact sheets
17
Situation Updates
9
Brochures
6
Resource Platforms
5
Infographics
4
Countries / Regions
India
104
South Africa
85
Kenya
75
Global
72
Western and Central Europe
51
Ethiopia
38
Zambia
37
Tanzania
36
Uganda
36
Nigeria
33
Ghana
32
Nepal
28
Namibia
27
Liberia
27
Latin America and the Carribbean
26
Ukraine
25
Africa
25
Sierra Leone
22
Myanmar / Burma
21
Eastern Europe
20
Malawi
19
Syria
18
South–East Asia Region
18
Bangladesh
16
Indonesia
16
Rwanda
14
Eswatini/ Swaziland
14
Lesotho
12
Philippines
12
Russia
12
Botswana
12
Zimbabwe
11
Cambodia
10
Asia
10
Brazil
9
USA
7
Eastern Europe and Central Asia
7
Tajikistan
6
Mozambique
6
Germany
6
West and Central Africa
6
Sri Lanka
6
Georgia
6
Cameroon
5
Guinea
5
Middle East and North Africa
5
East and Southern Africa
5
Pakistan
5
North Macedonia
4
Thailand
4
Canada
4
Afghanistan
4
Western Pacific Region
4
Jamaica
4
Moldova
4
Sudan
4
Yemen
4
South Sudan
4
Colombia
3
Gambia
3
Iran
3
Kyrgyzstan
3
Burkina Faso
3
Haiti
3
Congo, Democratic Republic of
3
United Kingdom
3
Southern Africa
3
Lebanon
3
Vietnam
3
Iraq
3
Mexico
2
China
2
Albania
2
Laos
2
Senegal
2
Estonia
2
Peru
2
Morocco
2
Venezuela
2
Hungary
2
Jordan
2
Paraguay
2
Belarus
2
Argentina
2
Papua New Guinea
2
Poland
2
Bhutan
2
Switzerland
1
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Benin
1
Kazakhstan
1
Chile
1
Fiji
1
Singapore
1
Niger
1
Uzbekistan
1
Burundi
1
Bulgaria
1
Saudi Arabia
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Portugal
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Greece
1
Palestine
1
Mali
1
Angola
1
Chad
1
Libya
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
732
Clinical Guidelines
172
Public Health
118
Women & Child Health
88
Key Resources
81
Capacity Building
58
Pharmacy & Technologies
34
Annual Report MEDBOX
1
Toolboxes
Mental Health
457
HIV
185
COVID-19
112
Pharmacy
107
TB
102
AMR
95
Caregiver
66
Planetary Health
54
NCDs
46
Disability
41
Conflict
35
Refugee
34
Rapid Response
31
Ebola & Marburg
31
NTDs
30
Global Health Education
26
Specific Hazards
24
Health Financing Toolbox
16
Natural Hazards
15
2.0 Rapid Response
13
Malaria
9
Zika
9
Social Ethics
6
Polio
5
Cholera
2
Antimicrobials are precious agents for combating infectious diseases and had saved millions of lives throughout the world. However, the current trend of increasing antimicrobial resistance (AMR) has become a global health problem with increased morbidity and mortality in infectious diseases. Sri La...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
Overwhelming evidence shows that a range of health concerns—mental illness, substance dependence, HIV/AIDS, and noncommunicable diseases—affect prisoners disproportionately. But, while incarceration poses risks to health—including inadequate nutrition and exposure to violence—prisons also pr...
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long
been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still
kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas
of economically ...
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas of economically dis...
Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus
A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. The target audience for this guidance document incl...
Background:Neonatal mortality accounts for 43% of global under-five deaths and is decreasing more slowly than maternal or child mortality. Donor funding has increased for maternal, newborn, and child health (MNCH), but no analysis to date has disaggregated aid for newborns. We evaluated if and how a...
The publication of the Second Edition of the Emergency Drug Guidelines represents the culmination of the efforts of the National Drugs and Therapeutics Committee (NDTC) to publish clinical drug guidelines for common diseases seen in Fiji. These guidelines are targeted for health care professionals w...
The Disability inclusion guide for action supports ministries of health and their partners in both advancing health equity for persons with disabilities by identifying entry points, and planning appropriate actions that strengthen the health system through disability inclusion. It focuses on address...
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
"This is the final report of the six-year collaboration between the WHO Department of Mental Health and Substance Abuse and the Gulbenkian Global Mental Health Platform, an initiative of the Calouste Gulbenkian Foundation aimed at reducing the global burden of mental health through the development a...
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i...
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have learned over the last ten years: A summary of knowledge
acquired and produced by the UN system on drug-r...
The annual Joint Meeting of the Food and Agriculture Organization of the United Nations (FAO) Panel of Experts on Pesticide Residues in Food and the Environment and the World Health Organization (WHO) Core Assessment Group on Pesticide Residues (JMPR) was held in Rome, Italy, from 13 to 22 September...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool
for assessing and managing p...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
